On this page of StockholderLetter.com we present the latest annual shareholder letter from MANNATECH INC — ticker symbol MTEX. Reading current and past MTEX letters to shareholders can bring important insights into the investment thesis.

 •  4/22/2025 Letter Continued (Full PDF)
 •  4/27/2023 MTEX Stockholder Letter
 •  4/22/2024 MTEX Stockholder Letter
 •  More "Consumer Goods" Category Stockholder Letters
 •  MTEX Benford's Law Stock Score = 57

MTEX Shareholder/Stockholder Letter Transcript:

Annual Report 2024

To Our Shareholders
Throughout 2024, Mannatech continued to build on its legacy as a global leader in health and
wellness. This past year, we placed a major focus on operational efficiency   making significant
strides in overcoming challenges related to supply chain, regulatory uncertainty, and global logistics.
The results of these efforts are now reflected in our reporting margins and, we believe, have laid a
solid foundation for sustainable growth moving forward.
As the pioneer of glyconutrition, Mannatech is on a bold mission to make taking a daily multi-glycan
product as common as taking a multi-vitamin. With new science continuing to spotlight the
importance of glycans in human health, we are proud to remain at the forefront   leading innovation
and awareness in this exciting category. We also prioritized transparent and more frequent
communication with our Associates around the world, helping foster stronger connections and
alignment throughout our global community.
Product and operational innovation remained key priorities in 2024. The Luminovation   skincare line
saw continued rollout and success across multiple markets. North America introduced TruEdge   
Energy and Coffee products in 2024 and we recently augmented our TruHealth    line with the
launch of a new shake and the TruHealth Satiety product. South Korea launched its retention-focused
SMRT Subscription program, and in June 2024 we launched operations in Thailand, which we view as
a strategic market. In Mexico, a new management team ignited growth and momentum among new
and existing field leadership and we initiated a backoffice improvement project in North America   
laying the groundwork for a global rollout.
Our M5M Foundation continues to thrive. More than 5 million servings of PhytoBlend    powder
were donated to children in need across 12 countries. Our community outreach, fueled by the
compassion of our Associates and partners, continues to be a meaningful expression of who we are.
2024 was a year focused on stabilizing and strengthening our operations, and our team has done a
tremendous job. As we look ahead to 2025, we will continue identifying and addressing inefficiencies
   but with a sharper focus on refining our positioning, amplifying our messaging, and equipping our
Associates with the tools and training to ignite growth.
As always, we remain committed to creating an environment focused on increasing shareholder
value and attracting new Associates and customers.
We appreciate your continued belief in Mannatech and look forward to all we will achieve together
in 2025 and beyond.
^Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.



 4/22/2025 Letter Continued (Full PDF)